TrialThe pharmacogenomics journal2014

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.

S Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.